ADIM
CRSP icon

Alpha DNA Investment Management’s CRISPR Therapeutics CRSP Stock Holding History

Alpha DNA Investment Management’s Portfolio CRSP Stock Details CRSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-7,892
Closed -$494K – 204
2023
Q4 		$494K Buy
+7,892
New +$494K 0.19% 127